ImmunoGen Company
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.
Industry:
Geroscience
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
1981-01-01
Employees Number:
501-1000
Funding Status:
IPO
Total Funding:
55000000
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership